| RR | 95% CI | P-value |
---|---|---|---|
Age | Â | Â | Â |
   ≤45 year | 1.000 |  |  |
   >45 year | 1.057 | 0.846-1.321 | 0.624 |
T Classification | Â | Â | Â |
   T1 | 1.000 |  |  |
   T2 | 1.534 | 0.713-3.301 | 0.274 |
   T3 | 2.841 | 1.251-6.454 | 0.013 |
   T4 | 7.822 | 3.294-18.861 | <0.001 |
N Classification | Â | Â | Â |
   N0 | 1.000 |  |  |
   N1 | 2.597 | 1.431-4.713 | 0.002 |
   N2 | 7.621 | 3.667-15.836 | <0.001 |
   N3 | 2.846 | 0.646-12.551 | 0.167 |
M Classification | Â | Â | Â |
   M0 | 1.000 |  |  |
   M1 | 3.039 | 1.903-4.853 | <0.001 |
Clinical Stage | Â | Â | Â |
   I | 1.000 |  |  |
   II | 5.429 | 0.728-40.465 | 0.099 |
   III | 9.750 | 1.330-71.481 | 0.025 |
   IV | 20.065 | 2.724-147.736 | 0.003 |
ER Presence | Â | Â | Â |
   Negative | 1.000 |  |  |
   Positive | 0.758 | 0.486-1.183 | 0.223 |
PR Presence | Â | Â | Â |
   Negative | 1.000 |  |  |
   Positive | 0.511 | 0.327-0.800 | 0.003 |
HER-2 Presence | Â | Â | Â |
   Negative | 1.000 |  |  |
   Positive | 1.347 | 0.675-2.689 | 0.398 |
Bmi-1 Expression | Â | Â | Â |
   Low | 1.000 |  |  |
   High | 3.979 | 1.534-5.875 | 0.001 |